COVID-19 pandemic The Japanese Ministry of Health, Labour and Welfare signs a agreement with Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine that will be manufactured and distributed domestically by Takeda. The vaccine will be received from next year. Japan secures 150 million Novavax vaccine doses © The Japan Times Sources: The Japan Times